Nymox Pharmaceutical Corp (NYMX)
NASDAQ
News
Market Data
Register to chat with like-minded investors on our interactive forums.
| Year End December 30 2023 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Return on Assets (%) | -946.84 | -884.651 | -233.992 | -194.058 | -238.771 | -433.356 | -428.683 | -785.435 |
| Return on Equity (%) | 772.481 | 1419.556 | -368.423 | -251.904 | -419.739 | -1529.835 | 1331.174 | 483.94 |
| Return on Invested Capital (%) | 1529.293 | 2657.631 | -372.258 | -258.813 | -465.541 | -3002.161 | 869.542 | 461.054 |
| Operating Margin (%) | -4547.35 | -5908.482 | -3537.124 | -11313.793 | -233920 | N/A | N/A | N/A |
| Net Profit Margin (%) | -4632.155 | -5995.089 | -3543.144 | -11346.552 | -234760 | N/A | N/A | N/A |
| Book Value Per Share | -0.013 | -0.022 | 0.108 | 0.048 | 0.028 | -0.006 | -0.005 | -0.034 |
| Earnings Per Share | -0.267 | -0.238 | -0.164 | -0.185 | -0.151 | -0.147 | -0.073 | -0.095 |
| Cash Per Share | 0.041 | 0.015 | 0.123 | 0.074 | 0.046 | 0.01 | 0.016 | 0.001 |
| Working Capital Per Share | 0.014 | -0.023 | 0.107 | 0.046 | 0.026 | -0.009 | -0.007 | -0.034 |
| Operating Profit Per Share | 0.002 | 0.001 | 0.003 | 0.001 | N/A | N/A | N/A | N/A |
| EBIT Per Share | -0.267 | -0.238 | -0.164 | -0.185 | -0.151 | -0.147 | -0.073 | -0.095 |
| EBITDA Per Share | -0.267 | -0.238 | -0.164 | -0.185 | -0.151 | -0.147 | -0.073 | -0.095 |
| Free Cash Flow Per Share | -0.267 | -0.238 | -0.163 | -0.185 | -0.151 | -0.147 | -0.073 | -0.095 |
| Year End December 30 2023 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|---|---|
| Current Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Quick Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Inventory Turnover (Days) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Shares Outstanding | 49.12M | 56.38M | 64.68M | 71.22M | 77.96M | 85.55M | 90.52M | 93.54M |
| Year End December 30 2023 | Mar 2022 | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 |
|---|---|---|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Shares Outstanding | 90.28M | 91.27M | 91.27M | 90.52M | 90.52M | 91.27M | 93.27M | 93.54M |
| Return on Assets (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Return on Equity (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Return on Invested Capital (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Operating Margin (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Net Profit Margin (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Sales Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Book Value Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Earnings Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Cash Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Working Capital Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Operating Profit Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| EBIT Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| EBITDA Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Free Cash Flow Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Current Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Quick Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Inventory Turnover (Days) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Market Cap | 18.71M |
| Price to Earnings Ratio | -2.12 |
| Price to Sales Ratio | 0 |
| Price to Cash Ratio | 285.71 |
| Price to Book Ratio | -5.9 |
| Dividend Yield | - |
| Shares Outstanding | 93.54M |
| Average Volume (1 week) | 0 |
| Average Volume (1 Month) | 0 |
| 52 Week Change | - |
| 52 Week High | - |
| 52 Week Low | - |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
